According to Zealand Pharma's latest financial reports the company has $0.24 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.24 B | 42.59% |
2022-12-31 | $0.16 B | -21.99% |
2021-12-31 | $0.21 B | 4.6% |
2020-12-31 | $0.20 B | 5.09% |
2019-12-31 | $0.19 B | 11.37% |
2018-12-31 | $0.17 B | 65.96% |
2017-12-31 | $0.10 B | 133.76% |
2016-12-31 | $45.77 M | -25.41% |
2015-12-31 | $61.37 M | -27.3% |
2014-12-31 | $84.41 M | 46.82% |
2013-12-31 | $57.49 M | -33.25% |
2012-12-31 | $86.13 M | 15.61% |
2011-12-31 | $74.5 M | -3.57% |
2010-12-31 | $77.27 M | 175.4% |
2009-12-31 | $28.05 M | -29.55% |
2008-12-31 | $39.82 M | -18.85% |
2007-12-31 | $49.07 M |